account_balance
Investment manager · 13F filer · SEC CIK 1535610
Sabby Management, LLC
Reported value$12Mas of Jun 30, 2026
Positions16 8 new, 14 sold out
Top 10 weight94.7%SPY alone is 34%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
SPYState Street SPDR S&P
34.2%Added +101%
TOYOToyo Co Ltd
29.1%New
FAMIFarmmi Inc
7.0%New
CRVOCervomed Inc
6.4%New
TPSTTempest Therapeutics Inc
4.7%Added +2763%
PAVSParanovus Entertnmnt Tech Lt
4.7%New
BIAF2.5%CREG2.2%BCTXBriacell Therapeutics Corp
2.2%Added +9%
REVB1.8%SNESSenestech Inc
1.8%Trimmed −35%
BCTXL1.4%SPYState Street SPDR S&P
34.2%Added +101%
TOYOToyo Co Ltd
29.1%New
FAMI7.0%CRVO6.4%TPST4.7%PAVS4.7%BIAF2.5%CREGBCTX2.2%REVB1.8%SNESBCTXLBoxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
SPY State Street SPDR S&P 34.2% Added +101%TOYO Toyo Co Ltd 29.1% NewFAMI Farmmi Inc 7.0% NewCRVO Cervomed Inc 6.4% NewTPST Tempest Therapeutics Inc 4.7% Added +2763%PAVS Paranovus Entertnmnt Tech Lt 4.7% NewBIAF Bioaffinity Technologies 2.5% NewCREG Smart Power Corp 2.2% NewBCTX Briacell Therapeutics Corp 2.2% Added +9%REVB Revelation Biosciences Inc 1.8% Added +112%SNES Senestech Inc 1.8% Trimmed −35%BCTXL Briacell Therapeutics Corp 1.4% Trimmed −50%
What changed